WILMINGTON, MASSACHUSETTS (MARKET WIRE) DUSA Pharmaceuticals, Inc.(R) (NASDAQ GM: DUSA), a dermatology company that is developing and marketing Levulan(R) photodynamic therapy (PDT) and other products targeting patients with common skin conditions, today announced the filing of a shelf...
[read full story]